Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(1)
Other(2)

Detailed Status

unknown2
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

unknown267%
completed133%

Recent Activity

0 active trials
Showing 3 of 3
unknownnot_applicable

Burning Mouth Syndrome - New Diagnostic Criteria and Treatment

NCT05059418
unknownnot_applicable

Single Dose of Clonazepam Versus Intermiittent Diazepam for Febrile Seizures Prevention

NCT04364321
completednot_applicable

Efficacy and Safety of Melatonin and Clonazepam for IRBD

NCT03255642

Clinical Trials (3)

Showing 3 of 3 trials
NCT05059418Not Applicable

Burning Mouth Syndrome - New Diagnostic Criteria and Treatment

Unknown
NCT04364321Not Applicable

Single Dose of Clonazepam Versus Intermiittent Diazepam for Febrile Seizures Prevention

Unknown
NCT03255642Not Applicable

Efficacy and Safety of Melatonin and Clonazepam for IRBD

Completed

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3